Sabra Health Care REIT Files 8-K on Agreements

Ticker: SBRA · Form: 8-K · Filed: 2025-08-05T00:00:00.000Z

Sentiment: neutral

Topics: material-agreement, filing

TL;DR

Sabra Health Care REIT filed an 8-K today, reporting both new and terminated material agreements.

AI Summary

Sabra Health Care REIT, Inc. filed an 8-K on August 5, 2025, reporting the entry into and termination of a material definitive agreement. The filing also includes financial statements and exhibits.

Why It Matters

This filing indicates significant changes in Sabra's contractual relationships, which could impact its operational structure and financial performance.

Risk Assessment

Risk Level: medium — The termination of a material definitive agreement can signal potential disruptions or changes in business strategy that may affect the company's future performance.

Key Players & Entities

FAQ

What was the nature of the material definitive agreement entered into by Sabra Health Care REIT?

The filing indicates the entry into a material definitive agreement, but the specific details of this agreement are not provided in the summary information.

What led to the termination of the material definitive agreement?

The filing states that a material definitive agreement was terminated, but the reasons for this termination are not detailed in the provided summary.

When was this 8-K filing submitted?

The 8-K filing was submitted on August 5, 2025.

What is Sabra Health Care REIT's principal executive office address?

Sabra Health Care REIT, Inc.'s principal executive offices are located at 1781 Flight Way, Tustin, CA 92782.

Does this filing include any financial statements?

Yes, the filing explicitly lists 'Financial Statements and Exhibits' as an item of information.

From the Filing

0001193125-25-173630.txt : 20250805 0001193125-25-173630.hdr.sgml : 20250805 20250805171639 ACCESSION NUMBER: 0001193125-25-173630 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 14 CONFORMED PERIOD OF REPORT: 20250805 ITEM INFORMATION: Entry into a Material Definitive Agreement ITEM INFORMATION: Termination of a Material Definitive Agreement ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20250805 DATE AS OF CHANGE: 20250805 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Sabra Health Care REIT, Inc. CENTRAL INDEX KEY: 0001492298 STANDARD INDUSTRIAL CLASSIFICATION: REAL ESTATE INVESTMENT TRUSTS [6798] ORGANIZATION NAME: 05 Real Estate & Construction EIN: 272560479 STATE OF INCORPORATION: MD FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-34950 FILM NUMBER: 251186194 BUSINESS ADDRESS: STREET 1: 1781 FLIGHT WAY CITY: TUSTIN STATE: CA ZIP: 92782 BUSINESS PHONE: 888-393-8248 MAIL ADDRESS: STREET 1: 1781 FLIGHT WAY CITY: TUSTIN STATE: CA ZIP: 92782 8-K 1 d55008d8k.htm 8-K 8-K false 0001492298 0001492298 2025-08-05 2025-08-05     UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549     FORM 8-K     CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): August 5, 2025     SABRA HEALTH CARE REIT, INC. (Exact Name of Registrant as Specified in Its Charter)       Maryland   001-34950   27-2560479 (State of Incorporation)   (Commission File Number)   (I.R.S. Employer Identification No.)   1781 Flight Way Tustin , CA   92782 (Address of Principal Executive Offices)   (Zip Code) Registrant’s Telephone Number, Including Area Code: (888) 393-8248 (Former Name or Former Address, if Changed Since Last Report)     Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:     ☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)     ☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)     ☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))     ☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Securities registered pursuant to Section 12(b) of the Act:   Title of each class   Trading symbol(s)   Name of each exchange on which registered Common stock, $0.01 par value   SBRA   The Nasdaq Stock Market LLC Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter). Emerging growth company ☐ If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐       Item 1.01 Entry into a Material Definitive Agreement. On August 5, 2025, Sabra Health Care REIT, Inc. (the “ Company ”) entered into an equity distribution agreement (the “ Distribution Agreement ”) with Barclays Capital Inc., BMO Capital Markets Corp., BofA Securities, Inc., Citigroup Global Markets Inc., Citizens JMP Securities, LLC, Credit Agricole Securities (USA) Inc., Fifth Third Securities, Inc., Huntington Securities, Inc., J.P. Morgan Securities LLC, KeyBanc Capital Markets Inc., Mizuho Securities USA LLC, Morgan Stanley & Co. LLC, Raymond James & Associates, Inc., RBC Capital Markets, LLC, R

View on Read The Filing